Advancing CAR T-cell therapy
UCI Health hematologic oncologist offers insights and analysis of the transformative treatments
Dr. Stefan O. Ciurea, director of the UCI Health Hematopoietic Stem Cell Transplant and Cellular Therapy Program.
Orange, Calif. — CAR T-cell therapy is rapidly transforming treatment methods for some of the most intractable blood malignancies, raising hopes for better disease management and even progression-free survival, said UCI Health hematologic oncologist Stefan O. Ciurea, MD, director of the Hematopoietic Stem Cell Transplant and Cellular Therapy Program.
The fast-growing program at the Chao Family Comprehensive Cancer Center has performed nearly 200 procedures since it opened in May 2020 and an increasing number of CAR T-cell treatments. It is also one of a handful of U.S. programs that offers hematopoietic stem cell transplants to patients with a range of nonmalignant disorders, including multiple sclerosis and other autoimmune diseases.
At a recent medical conference, the UCI School of Medicine professor highlighted advances being made in clinical trials and other studies of CAR T-cell therapies for difficult-to-treat cancers, such as relapsed and refractory multiple myeloma and lymphomas. He also discussed strategies for managing side effects and optimizing patient outcomes.
To fully realize the potential of this revolutionary therapy, which uses the body's enhanced immune cells to combat blood and other cancers, Ciurea emphasized the importance of collaborative research, careful patient selection and close monitoring to advance the boundaries of CAR T-cell treatment.
View the presentation video ›
Related stories
- UCI Health awarded FACT accreditation for bone marrow transplantation and CAR T-cell therapy ›
- International stem cell transplant saves top OC chef from rare blood cancer ›
- Mantle cell lymphoma patient gets lifesaving transplant ›
- Bone marrow transplant: lifesaving care close to home ›
About UCI Health
UCI Health is the clinical enterprise of the University of California, Irvine, and the only academic health system in Orange County. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus, UCI Medical Center in Orange, Calif. The 459-bed, acute care hospital, listed among America’s Best Hospitals by U.S. News & World Report for 23 consecutive years, provides tertiary and quaternary care, ambulatory and specialty medical clinics, behavioral health and rehabilitation services. UCI Medical Center is home to Orange County’s only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. UCI Health serves a region of nearly 4 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on Facebook, Instagram, LinkedIn and Twitter.